Bafna Pharmaceuticals will list on the bourses with its public issue of 64,00,000 equity shares of Rs 10 each on June 27, 2008. The issue price was Rs 40 per equity share (including share premium of Rs 30 per equity share).
The issue will constitute 40.05% of the post issue paid-up capital of the company. The issue price is 4 times of the face value. The shares are proposed to be listed on the BSE.
Objects of the issue were as follows:
* Brand building in domestic markets Rs 10.44 crore.
* Part payment of loan from SBI Rs 4 crore.
* Brand building in international markets Rs 3.03 crore.
* Setting up R&D facilities Rs 3 crore.
* MHRA Accrediation Rs 1.08 crore.
* Public Issue expenses Rs 2.05 crore.
* Cameo Corporate Services is the Registrar to the Issue.
Ashika Capital and Keynote Corporate Services were the Lead Managers to the Issue
Source: Moneycontrol.com
Thursday, June 26, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment